SCHEMBL5686121

SCHEMBL5686121

CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)cn3)cc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 9/20 0.64
JAK1 P23458 3/20 0.64
JAK3 P52333 3/20 0.64
JAK2 O60674 3/20 0.64
CHEK1 O14757 2/20 0.53
RET P07949 2/20 0.53
TYK2 P29597 2/20 0.53
FLT3 P36888 2/20 0.53
RPS6KA3 P51812 2/20 0.53
MAPK10 P53779 2/20 0.53
STK4 Q13043 2/20 0.53
STK3 Q13188 2/20 0.53
MARK2 Q7KZI7 2/20 0.53
TBK1 Q9UHD2 2/20 0.53
RPS6KA6 Q9UK32 2/20 0.53
NUAK1 O60285 1/20 0.53
CSF1R P07333 1/20 0.53
FLT4 P35916 1/20 0.53
MAP3K9 P80192 1/20 0.53
ITK Q08881 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492001 0.85 SYK (0.62) SYKCSF1RAURKACDK2BRD4
SCHEMBL5686069 0.82 SYK (0.53) SYKJAK3KCNH2
SCHEMBL8735645 0.82 SYK (0.79) SYKJAK1JAK3JAK2CHEK1
SCHEMBL4488495 0.81 SYK (0.62) SYKJAK2FLT3MAPK10CSF1R
SCHEMBL4985685 0.79 MAPT (0.59) CHEK1MEN1MAPTKMT2ARAB9A
SCHEMBL737349 0.79 SYK (1.00) SYKJAK1JAK3JAK2CHEK1
SCHEMBL4499479 0.78 SYK (0.67) SYKJAK1JAK3JAK2AURKA
SCHEMBL735485 0.77 SYK (0.93) SYKJAK1JAK3JAK2CHEK1
SCHEMBL738226 0.76 SYK (1.00) SYKJAK1JAK3JAK2CHEK1
SCHEMBL29576356 0.76 JAK3 (0.56) SYKJAK1JAK3JAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed